Lin-Xiaoxi Ma, Benlong Yang, Shanshan Gu, Tianyu Ren, Dandan Gao, Jianmin Fang, Jiong Wu. "Safety and efficacy of neoadjuvant disitamab vedotin in combination with pertuzumab with or without toripalimab for HER2-positive breast cancer: An open-label phase II trial.." Journal of Clinical Oncology, 2025. doi:10.1200/jco.2025.43.16_suppl.e12596